|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Turning Point Therapeutics, Inc. (TPTX) |
|
|
$76.01 0.00 (0.00%) as of 4:30 Tue 8/16
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
48,170,000 |
| Market
Cap: |
3.66(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$76.01 - $76.01 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 116 |
| Guru Rank Value : 7.9 |
| Guru Occurances : 1 |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
1,183 |
| Total Sell Value |
$0 |
$0 |
$0 |
$88,654 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Alles Mark J |
Director |
– • – |
2022-08-17 |
4 |
D |
$76.00 |
$152,000 |
D/D |
(2,000) |
0 |
|
- |
|
| George Simeon |
Director |
– • – |
2022-08-17 |
4 |
D |
$76.00 |
$171,278,160 |
I/I |
(2,253,660) |
0 |
|
- |
|
| Sun Brian |
SVP & General Counsel |
• – – |
2022-08-17 |
4 |
D |
$76.00 |
$3,420,000 |
D/D |
(45,000) |
0 |
|
- |
|
| Hirmand Mohammad |
EVP and Chief Medical Officer |
• – – |
2022-08-17 |
4 |
D |
$76.00 |
$3,137,584 |
D/D |
(41,284) |
0 |
|
- |
|
| Countouriotis Athena |
President & CEO |
• • – |
2022-08-17 |
4 |
D |
$76.00 |
$8,432,884 |
D/D |
(110,959) |
0 |
|
- |
|
| Sabus Steve M |
SVP & Chief Commercial Officer |
• – – |
2022-08-17 |
4 |
D |
$76.00 |
$2,786,692 |
D/D |
(36,667) |
0 |
|
- |
|
| Tombesi Paolo |
EVP & Chief Financial Officer |
• – – |
2022-08-17 |
4 |
D |
$76.00 |
$2,263,128 |
D/D |
(29,778) |
0 |
|
- |
|
| Tombesi Paolo |
EVP & Chief Financial Officer |
• – – |
2022-07-27 |
4 |
S |
$74.94 |
$88,654 |
D/D |
(1,183) |
28,700 |
|
100% |
|
| Sabus Steve M |
SVP & Chief Commercial Officer |
• – – |
2022-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
36,667 |
36,667 |
|
- |
|
| Sun Brian |
SVP & General Counsel |
• – – |
2022-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
45,000 |
|
- |
|
| Reich Siegfried |
EVP & Chief Scientific Officer |
• – – |
2022-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
13,567 |
17,015 |
|
- |
|
| Reich Siegfried |
EVP & Chief Scientific Officer |
• – – |
2022-02-09 |
4 |
S |
$36.30 |
$14,411 |
D/D |
(397) |
3,448 |
|
-98% |
|
| Tombesi Paolo |
EVP & Chief Financial Officer |
• – – |
2022-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,283 |
29,883 |
|
- |
|
| North Annette |
EVP & General Counsel |
• – – |
2022-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,283 |
27,979 |
|
- |
|
| North Annette |
EVP & General Counsel |
• – – |
2022-02-09 |
4 |
S |
$36.30 |
$24,285 |
D/D |
(669) |
11,696 |
|
-98% |
|
| Countouriotis Athena |
President & CEO |
• • – |
2022-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
62,400 |
110,330 |
|
- |
|
| Countouriotis Athena |
President & CEO |
• • – |
2022-02-09 |
4 |
S |
$36.30 |
$107,847 |
D/D |
(2,971) |
47,930 |
|
-98% |
|
| Partridge Andrew John |
EVP & Chief Commercial Officer |
• – – |
2022-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,283 |
38,361 |
|
- |
|
| Partridge Andrew John |
EVP & Chief Commercial Officer |
• – – |
2022-02-09 |
4 |
S |
$36.30 |
$8,022 |
D/D |
(221) |
22,078 |
|
-98% |
|
| Hirmand Mohammad |
EVP & Chief Medical Officer |
• – – |
2022-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
33,983 |
40,821 |
|
- |
|
| Hirmand Mohammad |
EVP & Chief Medical Officer |
• – – |
2022-02-09 |
4 |
S |
$36.30 |
$24,285 |
D/D |
(669) |
6,838 |
|
-98% |
|
| North Annette |
EVP, General Counsel & Secty. |
• – – |
2021-08-30 |
4 |
AS |
$80.00 |
$800,000 |
D/D |
(10,000) |
12,365 |
|
-46% |
|
| North Annette |
EVP, General Counsel & Secty. |
• – – |
2021-08-30 |
4 |
OE |
$17.00 |
$170,000 |
D/D |
10,000 |
22,365 |
|
- |
|
| Tombesi Paolo |
EVP & Chief Financial Officer |
• – – |
2021-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
13,600 |
13,600 |
|
- |
|
| Partridge Andrew John |
EVP & Chief Commercial Officer |
• – – |
2021-07-14 |
4 |
S |
$74.90 |
$139,988 |
D/D |
(1,869) |
21,767 |
|
40% |
|
142 Records found
|
|
Page 1 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
